These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25884646)

  • 21. A G protein-coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1/Y5 receptor heterodimers.
    Kilpatrick LE; Humphrys LJ; Holliday ND
    Mol Pharmacol; 2015 Apr; 87(4):718-32. PubMed ID: 25637604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
    Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
    Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
    Keller M; Teng S; Bernhardt G; Buschauer A
    ChemMedChem; 2009 Oct; 4(10):1733-45. PubMed ID: 19672917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
    Wieland HA; Engel W; Eberlein W; Rudolf K; Doods HN
    Br J Pharmacol; 1998 Oct; 125(3):549-55. PubMed ID: 9806339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
    Weiss S; Keller M; Bernhardt G; Buschauer A; König B
    Bioorg Med Chem; 2008 Nov; 16(22):9858-66. PubMed ID: 18851917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divalent cations influencing neuropeptide Y receptor subtype binding in rat hippocampus and cortex membranes as well as in recombinant cells.
    Wieland HA; Willim K; Doods HN
    Regul Pept; 1998 Sep; 75-76():263-9. PubMed ID: 9802418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
    Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
    Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.
    Sjödin P; Holmberg SK; Akerberg H; Berglund MM; Mohell N; Larhammar D
    Biochem J; 2006 Jan; 393(Pt 1):161-9. PubMed ID: 16097949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
    Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
    Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain.
    Veyrat-Durebex C; Quirion R; Ferland G; Dumont Y; Gaudreau P
    Neuropeptides; 2013 Jun; 47(3):163-9. PubMed ID: 23410741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
    Dumont Y; Moyse E; Fournier A; Quirion R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptor.
    Vanderheyden PM; Van Liefde I; de Backer JP; Vauquelin G
    J Recept Signal Transduct Res; 1998; 18(4-6):363-85. PubMed ID: 9879066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat.
    Raposinho PD; Broqua P; Hayward A; Akinsanya K; Galyean R; Schteingart C; Junien J; Aubert ML
    Neuroendocrinology; 2000 Jan; 71(1):2-7. PubMed ID: 10644893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
    Van Liefde ; Vanderheyden PM; De Backer JP; Ebinger G; Vauquelin G
    J Recept Signal Transduct Res; 2001 Feb; 21(1):11-23. PubMed ID: 11693170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.